caBIG Town Hall Meeting

1
caBIG Town Hall Meeting

• July 18, 2005
• 200 PM to 400 PM (EDT)

2
Welcome to the caBIG Town Hall Meeting
Teleconference

• Introductory Remarks by
• Dr. Ken Buetow
• Director of the National Cancer Institute Center
  for Bioinformatics (NCICB)

3
caBIG Year 2

• Q1 There seems to be a shift in priorities for
  the caBIG project. Please explain how projects
  are being prioritized by caBIG leadership and
  how this prioritization affected the evaluation
  of the recent RFPs?

4
Percentage of Funding by Workspace/Working Group
Year One
Year Two Awards
Total Year 2 Funding Outlays
5
caBIG Year 2

• Q2(a) What were the RFPs funded in this round,
  who received the funding and what are the
  budgetary prospects and project priorities for
  the remainder of caBIG Year 2, ending February
  28, 2006?
• And
• Q2(b) What were the overall number of
  development projects funded for Year 2 in each
  Workspace? What are they? Who are the designated
  adopters for each, if they have been named?

6
caBIG Year 2

• Q3 Since the release CTMS software will be a
  major focus of caBIG in at least the short term,
  how can centers not specifically involved with
  the CTMS workspace assist with the development
  and implementation of current CTMS goals? What
  are the new plans/goals with respect to CTMS?
  How does this affect the entire caBIG project and
  how can we come together as a team to tackle
  these new challenges.

7
Summary of Cancer Center Needs
Clinical Data Management Tools Databases
8
caBIG Year 2

• Q4 Please help us understand the rationale
  behind the Year 2 funding decisions. Among other
  questions Why were cancer centers that
  contributed actively and valuably as unfunded
  participants during Year 1 not funded for WS
  participation?

9
caBIG Year 2

• Q5 Please discuss the programs thinking about
  the appropriate timing and considerations for
  adopter selection. One of the most successful
  projects to date is caTIES, and all team members
  will tell you that a great deal of that success
  is due to early identification of an enthusiastic
  adopter.

10
caBIG Year 2

• Q6 Could you please clarify the criteria used to
  determine the quality of proposals for those
  applying to be developers, adopters and
  participants? Who makes the decisions?

11
caBIG and Regulatory Compliance

• Q7 How will caBIG handle government regulatory
  compliances when dealing with foreign
  researchers?

12
caBIG and Government Initiatives

• Q8 How will the recent reports/initiatives like
  the President's Cancer Panel report
  (http//deainfo.nci.nih.gov/ADVISORY/pcp/pcp04-05r
  pt/ReportTrans.pdf) on Translational Research and
  the CTWG report (http//integratedtrials.nci.nih.g
  ov/ict/CTWG_report_June2005.pdf) be incorporated
  into caBIG at ALL levels?

13
caBIG and Big Picture

• Q9 How can we ensure that every caBIG project
  remembers its role in the 'big picture' while it
  appropriately focuses on details (e.g. start
  end of each conference call, f2f, etc.)?

14
caBIG FAQs and Documentation

• Q10 Are there any plans for consolidation of the
  technical information provided in the caBIO_USERS
  and other listservs into a FAQ, or for regularly
  published supplements to the original caCORE SDK
  documentation to include all this additional
  info?

15
caBIG Upcoming Activities

• Please take note of the following upcoming caBIG
  activities
• Imaging RFP In review process
• Upcoming Translational Medicine RFP
• Cancer Genome Project
• Industry Partners meeting in September
• Speakers Bureau coming soon

16

• Thank you!